Idiopathic pulmonary hemosiderosis with manifestations of multiple connective tissue and immune disorders. Treatment with cyclophosphamide.
D000293:Adolescent; D000974:Antibodies, Antinuclear / Q000302:isolation & purification; D001172:Arthritis, Rheumatoid / Q000209:etiology; D001706:Biopsy; D003095:Collagen Diseases / Q000209:etiology* / Q000276:immunology; D003238:Connective Tissue / Q000276:immunology; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D005921:Glomerulonephritis / Q000209:etiology; D006469:Hemoptysis / Q000188:drug therapy; D006486:Hemosiderosis / Q000150:complications / Q000276:immunology*; D006801:Humans; D007668:Kidney / Q000473:pathology; D008168:Lung / Q000473:pathology; D008171:Lung Diseases / Q000150:complications / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use; D012217:Rheumatoid Factor / Q000302:isolation & purification; D013717:Tenosynovitis / Q000209:etiology
D000974:Antibodies, Antinuclear; D003520:Cyclophosphamide; D012217:Rheumatoid Factor; D011241:Prednisone